Mastopexy using de-epithelialised dermoglandular flaps: a case series for maximal volume conservation following breast implants removal

Eur J Med Res. 2022 Aug 27;27(1):159. doi: 10.1186/s40001-022-00790-0.

Abstract

Aims and objective: Removal of implants without replacement is often requested, and the procedure is more commonly performed today than ever before. However, the resultant loss of body image, secondary to the loss of breast volume, is not an outcome, that a patient is looking forward to. There is a lack of information on the options available to the patients following explantation. This case series presents an option of breast volume preservation and reshaping during mastopexy after breast implant removal that can be offered to selected patients. In the current case series, de-epithelialised dermoglandular flap mastopexy was used as an autologous tissue for breast reshaping and remodelling.

Material and methods: Since 2015, ten patients were selected for de-epithelialised dermoglandular mastopexy using wise pattern or vertical scar. Surgery was performed under general anaesthesia as a day case. A vertically oriented bipedicular dermoglandular flap was used for vertical scar mastopexy in two patients, and eight patients had Wise pattern incisions. Of these eight patients, four had superomedial and four had inferiorly based flaps for dermoglandular mastopexy and closure. All patients had a preoperative cup size D or larger.

Results: All patients had adequate results with an acceptable breast cup size. There was no skin breakdown, nipple loss, haematoma or infection.

Conclusion: De-epithelialised dermoglandular flap mastopexy is a safe procedure and can be used as an option in selected patients.

Level of evidence: IV.

Keywords: Autoaugmentation; Bostwick flap; Dermoglandular flaps; Explantation surgery; Mastopexy.

MeSH terms

  • Breast Implants*
  • Cicatrix
  • Humans
  • Mammaplasty*
  • Patient Satisfaction
  • Retrospective Studies
  • Treatment Outcome